Profound Medical Corp Key Fundamental Indicators

PROF Stock

USD 6.68 0.38 5.38%

As of the 4th of February, Profound Medical holds the Semi Deviation of 2.98, risk adjusted performance of 0.0631, and Coefficient Of Variation of 1334.02. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profound Medical, as well as the relationship between them. Please check Profound Medical Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Profound Medical Corp is priced some-what accurately, providing market reflects its current price of 6.68 per share. Given that Profound Medical has jensen alpha of 0.2053, we recommend you to check out Profound Medical Corp's recent market performance to make sure the company can sustain itself at a future point.

Profound Medical Total Revenue

12.28 Million

Profound Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Profound Medical's valuation are provided below:

Gross Profit

10.4 M

Profit Margin

(2.75)

Market Capitalization

256.2 M

Enterprise Value Revenue

18.3644

Revenue

14.3 M

There are over one hundred nineteen available trending fundamental ratios for Profound Medical Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Profound Medical Corp recent fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Profound Medical's current Market Cap is estimated to increase to about 313.8 M. The Profound Medical's current Enterprise Value is estimated to increase to about 266.5 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Research And Ddevelopement To Revenue Capex To Revenue

At this time, Profound Medical's Selling General Administrative is most likely to increase significantly in the upcoming years. The Profound Medical's current Total Other Income Expense Net is estimated to increase to about 6 M, while Operating Income is projected to decrease to (29.7 M).

Build AI portfolio with Profound Stock

Profound Medical Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

49 M

80.8 M

36.8 M

Slightly volatile

Short and Long Term Debt Total

6.7 M

5.9 M

5.4 M

Slightly volatile

Total Current Liabilities

5.3 M

7.5 M

3.9 M

Slightly volatile

Total Stockholder Equity

38.9 M

69.5 M

29.6 M

Slightly volatile

Property Plant And Equipment Net

1.4 M

944.2 K

991.3 K

Slightly volatile

Accounts Payable

2.3 M

1.5 M

Slightly volatile

Cash

34.9 M

63.1 M

26.7 M

Slightly volatile

Non Current Assets Total

1.3 M

2.9 M

Slightly volatile

Cash And Short Term Investments

35.6 M

63.1 M

27.1 M

Slightly volatile

Net Receivables

4.1 M

8.1 M

3.4 M

Slightly volatile

Common Stock Total Equity

255.4 M

243.3 M

119.1 M

Slightly volatile

Common Stock Shares Outstanding

29.9 M

28.5 M

11.6 M

Slightly volatile

Liabilities And Stockholders Equity

49 M

80.8 M

36.8 M

Slightly volatile

Non Current Liabilities Total

5.1 M

3.7 M

4.1 M

Slightly volatile

Other Current Assets

876.3 K

1.5 M

701.6 K

Slightly volatile

Other Stockholder Equity

12.5 M

24.5 M

9.6 M

Slightly volatile

Total Liabilities

10.1 M

11.3 M

7.2 M

Slightly volatile

Property Plant And Equipment Gross

2.1 M

3.7 M

1.7 M

Slightly volatile

Total Current Assets

44.6 M

79.4 M

33.8 M

Slightly volatile

Short Term Debt

1.8 M

2.3 M

1.5 M

Slightly volatile

Intangible Assets

223.2 K

234.9 K

885 K

Pretty Stable

Common Stock

340 M

323.8 M

128.8 M

Slightly volatile

Other Liabilities

1.1 M

878.6 K

726.8 K

Slightly volatile

Net Tangible Assets

38 M

59 M

30.1 M

Slightly volatile

Long Term Debt

5.7 M

3.4 M

5.4 M

Very volatile

Long Term Debt Total

6.4 M

10.2 M

6.9 M

Slightly volatile

Capital Surpluse

23.6 M

22.5 M

11.9 M

Slightly volatile

Short and Long Term Debt

1.9 M

1.6 M

1.4 M

Slightly volatile

Property Plant Equipment

1.7 M

2 M

1.2 M

Slightly volatile

Net Invested Capital

56 M

74.8 M

38 M

Slightly volatile

Net Working Capital

50 M

71.9 M

30.8 M

Slightly volatile

Capital Stock

208.1 M

323.8 M

151 M

Slightly volatile

Profound Medical Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

1.1 M

1 M

823.3 K

Slightly volatile

Interest Expense

737.9 K

693 K

705.7 K

Very volatile

Selling General Administrative

27.9 M

26.6 M

8.7 M

Slightly volatile

Other Operating Expenses

25.7 M

47.9 M

20.5 M

Slightly volatile

Research Development

10.8 M

18.6 M

8.7 M

Slightly volatile

Total Operating Expenses

23.4 M

43.9 M

18.8 M

Slightly volatile

Interest Income

2 M

1.9 M

1.1 M

Very volatile

Cost Of Revenue

2.6 M

4 M

1.8 M

Slightly volatile

Selling And Marketing Expenses

5.4 M

10.9 M

4.2 M

Slightly volatile

Reconciled Depreciation

1.5 M

1.1 M

Slightly volatile

Profound Medical Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Stock Based Compensation

2.5 M

3 M

1.8 M

Slightly volatile

Begin Period Cash Flow

29.5 M

30.1 M

21 M

Slightly volatile

Depreciation

1.1 M

773.8 K

Slightly volatile

Other Non Cash Items

218 K

229.5 K

2.5 M

Slightly volatile

Total Cash From Financing Activities

66 M

62.9 M

21.8 M

Slightly volatile

End Period Cash Flow

35.1 M

63.1 M

27.2 M

Slightly volatile

Sale Purchase Of Stock

15.6 M

10.4 M

17.7 M

Slightly volatile

Change To Netincome

4.6 M

7.9 M

4.9 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

29.06

22.54

26.6077

Slightly volatile

PTB Ratio

3.89

3.98

3.9804

Slightly volatile

Days Sales Outstanding

309

277

304

Slightly volatile

Book Value Per Share

3.43

2.81

3.8688

Slightly volatile

Average Payables

2.7 M

2.6 M

1.7 M

Slightly volatile

Stock Based Compensation To Revenue

0.38

0.22

0.3715

Slightly volatile

Capex To Depreciation

0.34

0.36

0.8116

Pretty Stable

PB Ratio

3.89

3.98

3.9804

Slightly volatile

EV To Sales

24.74

18.35

23.0726

Slightly volatile

Payables Turnover

2.61

2.49

1.0398

Slightly volatile

Sales General And Administrative To Revenue

1.63

1.46

1.3658

Slightly volatile

Research And Ddevelopement To Revenue

2.41

1.83

2.0897

Very volatile

Capex To Revenue

0.0754

0.0992

0.0833

Slightly volatile

Cash Per Share

3.56

2.55

4.0509

Slightly volatile

Days Payables Outstanding

144

152

1.6 K

Slightly volatile

Income Quality

0.62

0.76

0.6655

Slightly volatile

Intangibles To Total Assets

0.0041

0.0043

0.0524

Very volatile

Current Ratio

8.39

9.47

11.2085

Pretty Stable

Tangible Book Value Per Share

3.15

2.79

3.6453

Slightly volatile

Receivables Turnover

1.34

1.36

1.3964

Pretty Stable

Shareholders Equity Per Share

3.43

2.81

3.8688

Slightly volatile

Debt To Equity

0.0926

0.0975

0.7835

Slightly volatile

Capex Per Share

0.0317

0.0333

0.115

Slightly volatile

Graham Net Net

2.85

2.47

3.4721

Slightly volatile

Average Receivables

3.9 M

2.9 M

3.6 M

Slightly volatile

Revenue Per Share

0.42

0.5

0.4955

Slightly volatile

Interest Debt Per Share

0.23

0.24

4.5171

Slightly volatile

Debt To Assets

0.0797

0.0839

0.6698

Slightly volatile

Price Book Value Ratio

3.89

3.98

3.9804

Slightly volatile

Days Of Payables Outstanding

144

152

1.6 K

Slightly volatile

Ebt Per Ebit

1.16

0.97

1.2342

Slightly volatile

Company Equity Multiplier

1.6

1.34

1.3648

Pretty Stable

Long Term Debt To Capitalization

0.0504

0.0531

0.296

Slightly volatile

Total Debt To Capitalization

0.0854

0.0899

0.3288

Slightly volatile

Debt Equity Ratio

0.0926

0.0975

0.7835

Slightly volatile

Quick Ratio

7.82

8.67

10.6634

Slightly volatile

Net Income Per E B T

0.8

0.9

0.9919

Slightly volatile

Cash Ratio

6.6

7.53

9.5395

Slightly volatile

Days Of Sales Outstanding

309

277

304

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

1.13

1.18

1.0409

Slightly volatile

Price To Book Ratio

3.89

3.98

3.9804

Slightly volatile

Fixed Asset Turnover

12.29

11.71

4.6607

Slightly volatile

Debt Ratio

0.0797

0.0839

0.6698

Slightly volatile

Price Sales Ratio

29.06

22.54

26.6077

Slightly volatile

Asset Turnover

0.096

0.14

0.1417

Slightly volatile

Gross Profit Margin

0.39

0.59

0.444

Slightly volatile

Price Fair Value

3.89

3.98

3.9804

Slightly volatile

Profound Medical Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

313.8 M

307.6 M

223.9 M

Slightly volatile

Enterprise Value

266.5 M

250.4 M

200.5 M

Slightly volatile

Profound Fundamental Market Drivers

Profound Upcoming Events

	5th of March 2024 Upcoming Quarterly Report	View
	8th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	5th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Profound Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Return On Equity. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.

Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.

Earnings Share

(1.32)

Revenue Per Share

0.492

Quarterly Revenue Growth

0.868

Return On Assets

(0.62)

Return On Equity

(1.24)

Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.

It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.

Profound Medical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Profound Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Profound Medical.

0.00

11/06/2025

No Change 0.00

0.0

In 3 months and 1 day

02/04/2026

0.00

If you would invest 0.00 in Profound Medical on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Profound Medical Corp or generate 0.0% return on investment in Profound Medical over 90 days. Profound Medical is related to or competes with TriSalus Life, MaxCyte, Perspective Therapeutics, LENSAR, Anteris Technologies, Nano X, and Prenetics Global. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that devel... More

Profound Medical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Profound Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Profound Medical Corp upside and downside potential and time the market with a certain degree of confidence.

	Downside Deviation	3.15
	Information Ratio	0.061
	Maximum Drawdown	19.12
	Value At Risk	(4.14)
	Potential Upside	7.37

Profound Medical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Profound Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Profound Medical's standard deviation. In reality, there are many statistical measures that can use Profound Medical historical prices to predict the future Profound Medical's volatility.

	Risk Adjusted Performance	0.0631
	Jensen Alpha	0.2053
	Total Risk Alpha	0.0522
	Sortino Ratio	0.0733
	Treynor Ratio	0.1707

Hype

Prediction

Low	Estimated	High
3.15	7.08	11.01

Details

Intrinsic

Valuation

Low	Real	High
4.48	8.41	12.34

Details

Naive

Forecast

Low	Next	High
2.99	6.92	10.85

Details

5 Analysts

Consensus

Low	Target	High
11.24	12.35	13.71

Details

Profound Medical February 4, 2026 Technical Indicators

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

	Risk Adjusted Performance	0.0631
	Market Risk Adjusted Performance	0.1807
	Mean Deviation	2.86
	Semi Deviation	2.98
	Downside Deviation	3.15
	Coefficient Of Variation	1334.02
	Standard Deviation	3.79
	Variance	14.39
	Information Ratio	0.061
	Jensen Alpha	0.2053
	Total Risk Alpha	0.0522
	Sortino Ratio	0.0733
	Treynor Ratio	0.1707
	Maximum Drawdown	19.12
	Value At Risk	(4.14)
	Potential Upside	7.37
	Downside Variance	9.95
	Semi Variance	8.88
	Expected Short fall	(3.54)
	Skewness	0.3974
	Kurtosis	0.7663

Profound Medical Corp Backtested Returns

Profound Medical appears to be slightly risky, given 3 months investment horizon. Profound Medical Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0977, which implies the firm had a 0.0977 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Profound Medical Corp, which you can use to evaluate the volatility of the company. Please evaluate Profound Medical's Risk Adjusted Performance of 0.0631, semi deviation of 2.98, and Coefficient Of Variation of 1334.02 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Profound Medical holds a performance score of 7. The company holds a Beta of 1.61, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Profound Medical will likely underperform. Please check Profound Medical's skewness, and the relationship between the value at risk and day median price , to make a quick decision on whether Profound Medical's historical price patterns will revert.

Auto-correlation

-0.42

Modest reverse predictability

Profound Medical Corp has modest reverse predictability. Overlapping area represents the amount of predictability between Profound Medical time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Profound Medical Corp price movement. The serial correlation of -0.42 indicates that just about 42.0% of current Profound Medical price fluctuation can be explain by its past prices.

	Correlation Coefficient	-0.42
	Spearman Rank Test	0.06
	Residual Average	0.0
	Price Variance	0.19

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Profound Medical

Return On Equity Over Time

Profound Total Stockholder Equity

Total Stockholder Equity

38.91 Million

At this time, Profound Medical's Total Stockholder Equity is most likely to increase significantly in the upcoming years.

Based on the latest financial disclosure, Profound Medical Corp has a Return On Equity of -1.2449. This is 94.81% lower than that of the Health Care Equipment & Supplies sector and 85.74% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

Profound Medical Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Profound Medical's current stock value. Our valuation model uses many indicators to compare Profound Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profound Medical competition to find correlations between indicators driving Profound Medical's intrinsic value. More Info.

Profound Medical Corp is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Profound Medical's Return On Equity is most likely to slightly grow in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Profound Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Profound Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.

Profound Medical is currently under evaluation in return on equity category among its peers.

Profound Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Profound Medical from analyzing Profound Medical's financial statements. These drivers represent accounts that assess Profound Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Profound Medical's important valuation drivers and their relationship over time.

	2021	2022	2023	2024	2025	2026 (projected)
Market Cap	291.8M	300.8M	235.1M	267.5M	307.6M	313.8M
Enterprise Value	226.0M	262.5M	216.8M	217.7M	250.4M	266.5M

Profound Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Profound Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Profound Medical's managers, analysts, and investors.

Environmental

Governance

Social

Profound Fundamentals

	Return On Equity	-1.24
	Return On Asset	-0.62
	Profit Margin	(2.75) %
	Operating Margin	(1.69) %
	Current Valuation	262.56 M
	Shares Outstanding	36.29 M
	Shares Owned By Insiders	11.36 %
	Shares Owned By Institutions	34.55 %
	Number Of Shares Shorted	1.13 M
	Price To Book	8.76 X
	Price To Sales	17.92 X
	Revenue	10.17 M
	Gross Profit	10.36 M
	EBITDA	(25.59 M)
	Net Income	(27.82 M)
	Cash And Equivalents	46.21 M
	Cash Per Share	2.21 X
	Total Debt	5.12 M
	Debt To Equity	0.02 %
	Current Ratio	17.36 X
	Book Value Per Share	1.06 X
	Cash Flow From Operations	(23.45 M)
	Short Ratio	4.15 X
	Earnings Per Share	(1.32) X
	Target Price	12.35
	Number Of Employees	142
	Beta	0.36
	Market Capitalization	256.23 M
	Total Asset	70.23 M
	Retained Earnings	(245.17 M)
	Working Capital	62.5 M
	Current Asset	9 K
	Current Liabilities	761 K
	Net Asset	70.23 M

About Profound Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	481.9 K	391.7 K
Total Revenue	11.7 M	12.3 M
Cost Of Revenue	4 M	2.6 M
Stock Based Compensation To Revenue	0.22	0.38
Sales General And Administrative To Revenue	1.46	1.63
Research And Ddevelopement To Revenue	1.83	2.41
Capex To Revenue	0.10	0.08
Revenue Per Share	0.50	0.42
Ebit Per Revenue	(2.79)	(2.93)

Currently Active Assets on Macroaxis

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill
CSAN	Cosan SA ADR
RKT	Rocket Companies

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:

How To Invest In Profound

Details

Is Profound Stock a good investment?

Details

What is Profound Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Earnings Share

(1.32)

Revenue Per Share

0.492

Quarterly Revenue Growth

0.868

Return On Assets

(0.62)

Return On Equity

(1.24)

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales
Price To Sales Ratio		0.52	-0.22	-0.25	0.59	0.69	-0.35	0.52	0.99
Ptb Ratio	0.52		-0.19	-0.75	0.64	0.69	-0.16	1.0	0.61
Days Sales Outstanding	-0.22	-0.19		0.24	-0.3	-0.36	0.18	-0.19	-0.17
Book Value Per Share	-0.25	-0.75	0.24		-0.82	-0.78	-0.03	-0.75	-0.28
Free Cash Flow Yield	0.59	0.64	-0.3	-0.82		0.86	-0.03	0.64	0.57
Average Payables	0.69	0.69	-0.36	-0.78	0.86		-0.35	0.69	0.66
Capex To Depreciation	-0.35	-0.16	0.18	-0.03	-0.03	-0.35		-0.16	-0.34
Pb Ratio	0.52	1.0	-0.19	-0.75	0.64	0.69	-0.16		0.61
Ev To Sales	0.99	0.61	-0.17	-0.28	0.57	0.66	-0.34	0.61

Profound Medical Corp Key Fundamental Indicators

Profound Medical Total Revenue

12.28 Million

Profound Medical Balance Sheet

Profound Medical Income Statement

Profound Medical Cash Flow Statement

Financial Ratios

Profound Medical Valuation Data

Profound Fundamental Market Drivers

Profound Upcoming Events

Profound Return On Equity Driver Correlations

Profound Medical 'What if' Analysis

Profound Medical Upside/Downside Indicators

Profound Medical Market Risk Indicators

Profound Medical February 4, 2026 Technical Indicators

Profound Medical Corp Backtested Returns

Auto-correlation

Modest reverse predictability

Profound Total Stockholder Equity

Total Stockholder Equity

38.91 Million

Profound Medical Corp Fundamental Drivers Relationships

Profound Return On Equity Peer Comparison

Profound Medical Current Valuation Drivers

Profound Medical ESG Sustainability

Profound Fundamentals

About Profound Medical Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Profound Medical Corp Key Fundamental Indicators

Profound Medical Total Revenue

12.28 Million

Profound Medical Balance Sheet

Profound Medical Income Statement

Profound Medical Cash Flow Statement

Financial Ratios

Profound Medical Valuation Data

Profound Fundamental Market Drivers

Profound Upcoming Events

Profound Return On Equity Driver Correlations

Profound Medical 'What if' Analysis

Profound Medical Upside/Downside Indicators

Profound Medical Market Risk Indicators

Profound Medical February 4, 2026 Technical Indicators

Profound Medical Corp Backtested Returns

Auto-correlation

Modest reverse predictability

Profound Total Stockholder Equity

Total Stockholder Equity

38.91 Million

Profound Medical Corp Fundamental Drivers Relationships

Profound Return On Equity Peer Comparison

Profound Medical Current Valuation Drivers

Profound Medical ESG Sustainability

Profound Fundamentals

About Profound Medical Fundamental Analysis

Currently Active Assets on Macroaxis

Related Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY